Coriell Personalized Medicine Collaborative

From SNPedia

The CPMC is enrolling individuals in a research study to investigate the impact of personalized medicine on health outcomes. Over the next several years, study participants will receive personalized genetic results for their risks of complex diseases such as cancer, heart disease and diabetes. Participants will be asked to complete follow-up questionnaires to inform the medical and scientific community about the utility of using genome information in medical care.

Signup is free, but requires a visit to New Jersey. Participants are tested on an Affymetrix GenomeWide 6 microarray, however raw data is not provided to participants. This has been discussed in more detail at thinkgene.

These Health Conditions are being investigated, via these specific snps.

	Summary
Rs10490924	age related macular degeneration
Rs1333049	increased risk for CAD
Rs16901979	risk for prostate cancer
Rs1800562	hemochromatosis
Rs3821236	risk of Systemic lupus erythematosus
Rs7754840	risk for type-2 diabetes
Rs910873	melanoma